Product image of Linezolid Milpharm (Linezolid) supplied by GNH India

Linezolid Milpharm

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Milpharm (Linezolid)

Linezolid, the active ingredient in Linezolid Milpharm, is an oxazolidinone antibiotic presented as an oral formulation for oral use. It treats infections caused by resistant Gram‑positive bacteria, including MRSA and VRE, and is used in community‑acquired pneumonia and skin infections.

GNH India supplies Linezolid Milpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Milpharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is indicated for infections caused by resistant Gram‑positive organisms and acts by inhibiting bacterial protein synthesis.

  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: provides effective bacterial eradication in resistant cases.
  • Vancomycin‑resistant Enterococcus (VRE) infections: offers an alternative treatment option when vancomycin fails.
  • Community‑acquired pneumonia: achieves clinical cure by targeting susceptible pathogens.
  • Skin and soft‑tissue infections: reduces bacterial load and promotes healing in complicated cases.

How It Works

  • Linezolid binds to the 50S ribosomal subunit of susceptible bacteria, preventing the formation of the initiation complex required for protein synthesis. This inhibition halts bacterial growth, leading to a bacteriostatic effect against Gram‑positive organisms, including strains resistant to other antibiotic classes.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: transient cranial discomfort.
  • Metallic taste: altered taste perception.
  • Vomiting: occasional emesis.
  • Insomnia: difficulty sleeping.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Peripheral neuropathy: tingling or numbness in extremities.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Myelosuppression: bone‑marrow suppression affecting blood cells.
  • Lactic acidosis: rare metabolic disturbance.
  • Optic neuritis: visual disturbances requiring prompt evaluation.

Precautions & Warnings

Before prescribing Linezolid, clinicians should consider several safety factors.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly.
  • Concomitant serotonergic agents: avoid due to risk of serotonin syndrome.
  • Myelosuppression risk: perform baseline and periodic complete blood counts.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): may precipitate serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): increase risk of serotonin toxicity.
  • Rifampin: induces metabolism, reducing linezolid exposure.
  • Carbamazepine: decreases linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
  • Erythromycin: can raise linezolid levels, watch for toxicity.
  • Tizanidine: may increase sedation and hypotension.

Frequently Asked Questions

Linezolid Milpharm is used to treat infections caused by resistant Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE), community‑acquired pneumonia, and complicated skin and soft‑tissue infections.

Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex. This blocks translation of essential proteins, resulting in a bacteriostatic effect against susceptible Gram‑positive organisms.

The prescribed dose is determined by the treating clinician based on the type and severity of infection, patient weight, renal and hepatic function, and other clinical factors. Typical adult regimens often involve 600 mg every 12 hours, but exact dosing must follow the prescriber’s order.

Safety data in pregnancy and lactation are limited. Linezolid should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linezolid offers oral administration and activity against both MRSA and VRE, whereas vancomycin is administered intravenously and lacks reliable activity against VRE. Linezolid may be preferred for patients who need oral therapy or have vancomycin‑resistant infections, but each drug’s safety profile and bacterial susceptibility guide selection.

Store Linezolid Milpharm at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Linezolid Milpharm is taken orally, with or without food, as directed by the prescribing clinician. The tablets should be swallowed whole with water and not chewed or crushed unless specifically instructed.

Serious risks include thrombocytopenia, peripheral neuropathy, serotonin syndrome when combined with serotonergic drugs, and myelosuppression. Patients should be monitored regularly for blood‑cell abnormalities and signs of neuropathy, and serotonergic agents should be avoided.

Linezolid is contraindicated in individuals with known hypersensitivity to linezolid or any component of the formulation, and it should be avoided in patients currently receiving monoamine oxidase inhibitors. Caution is also advised for those with pre‑existing bone‑marrow suppression or uncontrolled hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT